JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

JNJ

227.84

+1.49%↑

ISRG

522.43

-0.51%↓

ABT

105.93

-2.09%↓

MDT

100.66

-0.05%↓

A

133.89

-1.33%↓

Search

Cartesian Therapeutics Inc

Затворен

7.23 -1.36

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

7.09

Максимум

7.41

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+359.92% upside

Дивиденти

By Dow Jones

Следващи печалби

11.03.2026 г.

Cartesian Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

27.01.2026 г., 23:07 ч. UTC

Печалби

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

27.01.2026 г., 21:27 ч. UTC

Печалби

Texas Instruments 4Q Sales Rise, Profit Falls

27.01.2026 г., 23:55 ч. UTC

Пазарно говорене

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

27.01.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

27.01.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Asset-Impairment Losses Weighed on Earnings

27.01.2026 г., 23:20 ч. UTC

Печалби

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation Posts Net Loss for Second Consecutive Year

27.01.2026 г., 23:19 ч. UTC

Печалби

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

27.01.2026 г., 23:18 ч. UTC

Печалби

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

27.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

27.01.2026 г., 23:07 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

27.01.2026 г., 22:17 ч. UTC

Пазарно говорене

U.S. Dollar Slips Following Trump Comments -- Market Talk

27.01.2026 г., 22:06 ч. UTC

Печалби

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

27.01.2026 г., 21:51 ч. UTC

Печалби

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

27.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

27.01.2026 г., 21:43 ч. UTC

Печалби

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

27.01.2026 г., 21:41 ч. UTC

Печалби

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

27.01.2026 г., 21:38 ч. UTC

Печалби

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: Modest Profit From F&I International in 2025

27.01.2026 г., 21:32 ч. UTC

Печалби

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

27.01.2026 г., 21:31 ч. UTC

Печалби

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

27.01.2026 г., 21:30 ч. UTC

Печалби

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

27.01.2026 г., 21:29 ч. UTC

Печалби

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

27.01.2026 г., 21:28 ч. UTC

Печалби

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Сравнение с други в отрасъла

Ценова промяна

Cartesian Therapeutics Inc Прогноза

Ценова цел

By TipRanks

359.92% нагоре

12-месечна прогноза

Среден 35 USD  359.92%

Висок 44 USD

Нисък 16 USD

Според 8 анализатори от Wall Street, предложили 12-месечна ценова цел за Cartesian Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

8 ratings

6

Купи

2

Задържане

0

Продай

Финанси

$

help-icon Live chat